Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Plasma cell 1

Conditions

Solid Tumor 1Prostatic Neoplasms 1Lung Neoplasms 1Immunoglobulin Light-chain Amyloidosis 1Endometrial Neoplasms 1Carcinoma, Non-Small-Cell Lung 1Breast Neoplasms 1Amyloidosis 1

Interventions

miridesap 3Dexamethasone 2Calcium Dobesilate 2venetoclax 1pomalidomide 1pegfilgrastim 1Technetium Tc 99m Pyrophosphate 1Technetium 1Surveys and Questionnaires 1Melphalan 1Interleukin-2 1Granulocyte-Macrophage Colony-Stimulating Factor 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 1 × Amyloidosis × Technetium × Clear all
NCT05951816 2023-07-19

A Phase 1 Study of 99mTc-p5+14 in Healthy Volunteers and Patients With AL or ATTR Systemic Amyloidosis

University of Tennessee Graduate School of Medicine

Phase 1 Unknown
35 enrolled
Plasma cell

Immunoglobulin Light-chain Amyloidosis, Amyloidosis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡